| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 250,470 | 187,414 | 100,948 | | Cost of Revenue | 136,434 | 100,886 | 56,902 | | | Gross Profit | 114,036 | 86,528 | 44,046 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 63,343 | 53,153 | 29,054 | | Non Recurring |
-
|
-
|
-
| | Others | 28,224 | 18,685 | 11,011 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 22,468 | 14,689 | 3,981 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,135) | (23,999) | 9,499 | | Earnings Before Interest And Taxes | 19,332 | (9,310) | 13,479 | | Interest Expense | 29,980 | 32,105 | 28,215 | | Income Before Tax | (10,647) | (41,415) | (14,735) | | Income Tax Expense | (79) | 813 | 217 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,569) | (42,228) | (14,952) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (10,569) | (42,228) | (14,952) | | Preferred Stock And Other Adjustments | (807) | (794) | (676) | | | Net Income Applicable To Common Shares | ($11,376) | ($43,022) | ($15,628) |
|
0.29% Nasdaq 
0.22 (3.32%) 
Income Statement
